Your browser doesn't support javascript.
loading
Stereotactic radiosurgery alone or combined with embolization for brain arteriovenous malformations: a systematic review and meta-analysis.
Russell, Dylan; Peck, Travis; Ding, Dale; Chen, Ching-Jen; Taylor, Davis G; Starke, Robert M; Lee, Cheng-Chia; Sheehan, Jason P.
Afiliação
  • Russell D; 1School of Medicine and.
  • Peck T; 1School of Medicine and.
  • Ding D; 2Department of Neurosurgery, University of Virginia, Charlottesville, Virginia.
  • Chen CJ; 2Department of Neurosurgery, University of Virginia, Charlottesville, Virginia.
  • Taylor DG; 2Department of Neurosurgery, University of Virginia, Charlottesville, Virginia.
  • Starke RM; 4Deparment of Neurological Surgery, University of Miami, Florida.
  • Lee CC; 3Deparment of Neurological Surgery, Taipei Veterans General Hospital, Taipei, Taiwan; and.
  • Sheehan JP; 2Department of Neurosurgery, University of Virginia, Charlottesville, Virginia.
J Neurosurg ; 128(5): 1338-1348, 2018 05.
Article em En | MEDLINE | ID: mdl-28498057
ABSTRACT
OBJECTIVE Embolization of brain arteriovenous malformations (AVMs) prior to stereotactic radiosurgery (SRS) has been reported to negatively affect obliteration rates. The goal of this systematic review and meta-analysis was to compare the outcomes of AVMs treated with embolization plus SRS (E+SRS group) and those of AVMs treated with SRS alone (SRS group). METHODS A literature review was performed using PubMed to identify studies with 10 or more AVM patients and obliteration data for both E+SRS and SRS groups. A meta-analysis was performed to compare obliteration rates between the E+SRS and SRS groups. RESULTS Twelve articles comprising 1716 patients were eligible for analysis. Among the patients with radiological follow-up data, complete obliteration was achieved in 48.4% of patients (330/681) in the E+SRS group compared with 62.7% of patients (613/978) in the SRS group. A meta-analysis of the pooled data revealed that the obliteration rate was significantly lower in the E+SRS group (OR 0.51, 95% CI 0.41-0.64, p < 0.00001). Symptomatic adverse radiation effects were observed in 6.6% (27/412 patients) and 11.1% (48/433 patients) of the E+SRS and SRS groups, respectively. The annual post-SRS hemorrhage rate was 2.0%-6.5% and 0%-2.0% for the E+SRS and SRS groups, respectively. The rates of permanent morbidity were 0%-6.7% and 0%-13.5% for the E+SRS and SRS groups, respectively. CONCLUSIONS Arteriovenous malformation treatment with combined embolization and SRS is associated with lower obliteration rates than those with SRS treatment alone. However, this comparison does not fully account for differences in the initial AVM characteristics in the E+SRS group as compared with those in the SRS group. Further studies are warranted to address these limitations.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Malformações Arteriovenosas Intracranianas / Radiocirurgia / Embolização Terapêutica Tipo de estudo: Prognostic_studies / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Malformações Arteriovenosas Intracranianas / Radiocirurgia / Embolização Terapêutica Tipo de estudo: Prognostic_studies / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article